D
Arcturus Therapeutics Holdings Inc. ARCT
$10.53 $0.232.23% NASDAQ
Recommendation
Prev Close
$10.30
Volume
358,185
Avg Vol (90D)
423,233
Market Cap
$279.33M
Dividend & Yield
--
52-Week Range
$8.04 - $45.00
P/E (TTM)
--
EPS (TTM)
-$3.01
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Look Under The Hood: IWV Has 29% Upside
4/17/2025 - ETF Channel
Arcturus Therapeutics Holdings (ARCT, $10.3) Aroon Indicator entered a Downtrend on April 16, 2025.
4/17/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Holdings (ARCT, $10.57) entered Uptrend as Momentum indicator ascends above 0 level on Apr 15, 2025
4/16/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $10.57) Aroon Indicator entered a Downtrend on April 15, 2025.
4/16/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $10.18) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 14, 2025
4/15/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $10.18) Aroon Indicator entered a Downtrend on April 14, 2025.
4/15/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $9.7) Aroon Indicator entered a Downtrend on April 11, 2025.
4/12/2025 - Tickeron - Stocks
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate
4/11/2025 - Zacks Investment Research
Arcturus Therapeutics Holdings (ARCT, $9.35) Aroon Indicator entered a Downtrend on April 10, 2025.
4/11/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
4/10/2025 - Business Wire
Arcturus Therapeutics Holdings (ARCT, $9.82) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $9.82) Aroon Indicator entered a Downtrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $8.91) Aroon Indicator entered a Downtrend on April 08, 2025.
4/9/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Holdings (ARCT, $9.09) Aroon Indicator entered a Downtrend on April 07, 2025.
4/8/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $9.11) Aroon Indicator entered a Downtrend on April 04, 2025.
4/5/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Holdings (ARCT, $9.49) Aroon Indicator entered a Downtrend on April 03, 2025.
4/4/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $10.2) Aroon Indicator entered a Downtrend on April 02, 2025.
4/3/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $9.43) Aroon Indicator entered a Downtrend on April 01, 2025.
4/2/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $10.59) Aroon Indicator entered a Downtrend on March 31, 2025.
4/1/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $11.58) Aroon Indicator entered a Downtrend on March 28, 2025.
3/29/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $12) Aroon Indicator entered a Downtrend on March 27, 2025.
3/28/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Holdings (ARCT, $11.95) Aroon Indicator entered a Downtrend on March 26, 2025.
3/27/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Holdings (ARCT, $11.95) RSI Indicator left the oversold zone on March 26, 2025
3/27/2025 - Tickeron - Technical Analysis
Arcturus Therapeutics Holdings (ARCT, $12.77) Aroon Indicator entered a Downtrend on March 25, 2025.
3/26/2025 - Tickeron - Stocks
Arcturus Therapeutics Holdings (ARCT, $13.27) Aroon Indicator entered a Downtrend on March 24, 2025.
3/25/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$152.31M
EBITDA (TTM)
-$91.33M
EBIT (TTM)
-$94.87M
Net Income (TTM)
-$80.94M
Balance Sheet
Total Assets (Q)
$344.07M
Total Debt (Q)
$28.55M
Total Liabilities (Q)
$103.09M
Book Value Per Share (Q)
$8.89
Cash Flow
Cash from Operations (TTM)
-$59.75M
Cash from Investing (TTM)
-$648.00K
Cash from Financing (TTM)
$5.42M
Net Change in Cash (TTM)
-$54.98M
Filings
Filing Date
Thursday, March 6, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
2.10
7-Day Total Return
18.18%
30-Day Total Return
-34.06%
60-Day Total Return
-37.10%
90-Day Total Return
-41.01%
Year to Date Total Return
-38.31%
1-Year Total Return
-61.90%
2-Year Total Return
-61.92%
3-Year Total Return
-58.28%
5-Year Total Return
-40.41%
52-week Low
Apr 07, 2025 - $8.04
52-week High
Jun 05, 2024 - $45.00
Valuation
Market Cap
$279.33M - Micro Cap
Enterprise Value
$70.86M
Price/Sales (TTM)
1.83
Price/Book (Q)
1.16
Dividends and Shares
Shares Outstanding
27.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
arcturusrx.com
Phone Number
858 900 2660
Address
10628 Science Center Drive
San Diego, CA 92121
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes... more
NASDAQ 04/17/2025 4:00PM Eastern Quotes delayed